CA2395701C - Dual stage hemodiafiltration cartridge - Google Patents
Dual stage hemodiafiltration cartridge Download PDFInfo
- Publication number
- CA2395701C CA2395701C CA002395701A CA2395701A CA2395701C CA 2395701 C CA2395701 C CA 2395701C CA 002395701 A CA002395701 A CA 002395701A CA 2395701 A CA2395701 A CA 2395701A CA 2395701 C CA2395701 C CA 2395701C
- Authority
- CA
- Canada
- Prior art keywords
- dialysate
- stage
- blood
- hemodiafiltration
- filtering element
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000009977 dual effect Effects 0.000 title description 13
- 210000004369 blood Anatomy 0.000 claims abstract description 76
- 239000008280 blood Substances 0.000 claims abstract description 76
- 239000012530 fluid Substances 0.000 claims abstract description 36
- 238000006467 substitution reaction Methods 0.000 claims abstract description 12
- 238000001914 filtration Methods 0.000 claims description 78
- 238000004891 communication Methods 0.000 claims description 12
- 239000003053 toxin Substances 0.000 claims description 9
- 231100000765 toxin Toxicity 0.000 claims description 9
- 238000007789 sealing Methods 0.000 claims description 8
- 230000007246 mechanism Effects 0.000 claims description 4
- 230000017531 blood circulation Effects 0.000 claims description 3
- 238000000638 solvent extraction Methods 0.000 claims 1
- 239000012510 hollow fiber Substances 0.000 abstract description 9
- 239000000835 fiber Substances 0.000 description 13
- 238000000034 method Methods 0.000 description 12
- 238000004382 potting Methods 0.000 description 12
- 238000010790 dilution Methods 0.000 description 8
- 239000012895 dilution Substances 0.000 description 8
- 108700012359 toxins Proteins 0.000 description 8
- 238000000502 dialysis Methods 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 238000009792 diffusion process Methods 0.000 description 6
- 230000008901 benefit Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 238000005534 hematocrit Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000001631 haemodialysis Methods 0.000 description 3
- 230000000322 hemodialysis Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- XFJBGINZIMNZBW-CRAIPNDOSA-N 5-chloro-2-[4-[(1r,2s)-2-[2-(5-methylsulfonylpyridin-2-yl)oxyethyl]cyclopropyl]piperidin-1-yl]pyrimidine Chemical compound N1=CC(S(=O)(=O)C)=CC=C1OCC[C@H]1[C@@H](C2CCN(CC2)C=2N=CC(Cl)=CN=2)C1 XFJBGINZIMNZBW-CRAIPNDOSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000011026 diafiltration Methods 0.000 description 2
- -1 e.g. Substances 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000008174 sterile solution Substances 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- HUWSZNZAROKDRZ-RRLWZMAJSA-N (3r,4r)-3-azaniumyl-5-[[(2s,3r)-1-[(2s)-2,3-dicarboxypyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-5-oxo-4-sulfanylpentane-1-sulfonate Chemical compound OS(=O)(=O)CC[C@@H](N)[C@@H](S)C(=O)N[C@@H]([C@H](C)CC)C(=O)N1CCC(C(O)=O)[C@H]1C(O)=O HUWSZNZAROKDRZ-RRLWZMAJSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 201000000523 end stage renal failure Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- ZBELDPMWYXDLNY-UHFFFAOYSA-N methyl 9-(4-bromo-2-fluoroanilino)-[1,3]thiazolo[5,4-f]quinazoline-2-carboximidate Chemical compound C12=C3SC(C(=N)OC)=NC3=CC=C2N=CN=C1NC1=CC=C(Br)C=C1F ZBELDPMWYXDLNY-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 238000013386 optimize process Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920005749 polyurethane resin Polymers 0.000 description 1
- 230000001698 pyrogenic effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 238000011277 treatment modality Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/342—Adding solutions to the blood, e.g. substitution solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3413—Diafiltration
- A61M1/3417—Diafiltration using distinct filters for dialysis and ultra-filtration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/342—Adding solutions to the blood, e.g. substitution solutions
- A61M1/3424—Substitution fluid path
- A61M1/3431—Substitution fluid path upstream of the filter
- A61M1/3434—Substitution fluid path upstream of the filter with pre-dilution and post-dilution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/342—Adding solutions to the blood, e.g. substitution solutions
- A61M1/3424—Substitution fluid path
- A61M1/3437—Substitution fluid path downstream of the filter, e.g. post-dilution with filtrate
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/14—Ultrafiltration; Microfiltration
- B01D61/145—Ultrafiltration
- B01D61/146—Ultrafiltration comprising multiple ultrafiltration steps
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D63/00—Apparatus in general for separation processes using semi-permeable membranes
- B01D63/02—Hollow fibre modules
- B01D63/04—Hollow fibre modules comprising multiple hollow fibre assemblies
- B01D63/043—Hollow fibre modules comprising multiple hollow fibre assemblies with separate tube sheets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2313/00—Details relating to membrane modules or apparatus
- B01D2313/13—Specific connectors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2313/00—Details relating to membrane modules or apparatus
- B01D2313/44—Cartridge types
Abstract
A dual-stage hemodiafiltration cartridge (10) includes a first hemodiafiltration stage (52) having a housing (62), blood inlet (55), dialysate outlet (23), and first hollow fibers (54); and a second hemodiafiltration stage (53) having a housing (63), blood outlet (16), dialysate inlet (17) and second hollow fibers (64). An inter-stage connector (12) connected to an end of each of the housings includes a header space adapted to allow flow of blood from the blood side of the first hollow fibers (54) to the blood side of the second hollow fibers (64). An inlet (15) allows substitution fluid to flow into the header space to dilute the blood therein. An interdialysate port (20) allows the dialysate to flow from the second hemodiafiltration stage (53) to the first hemodiafiltration stage (52).
Description
DUAL STAGE HEMODIAFILTRATION CARTRIDGE
Field of the Invention The present invention relates to hemodiafiltration devices and methods and, more particularly, to a new hemodiafiltration cartridge and its method of use.
Background of Invention Current treatment for End Stage Renal Disease (ESRD) essentially consists of hemodialysis process, wherein blood to be cleaned flows on one side of a semipermeable membrane and a physiologic solution, a dialysate, flows on the other side of the membrane,whereby toxins in the blood are transferred from one side to the other. The primary driving force in this treatment is diffusion. This process is generally effective in removing small Molecular Weight (MW) toxins such as urea and creatinine. However, this process is much less effective in removing middle range MW
substances, e.g., substances having a molecular weight higher than about 1 kDa, because of a low diffusion coefficient of such substances.
To a much lesser extent hemodiafiltration is used as a treatment modality. In hemodiafiltration, diffusion is combined with filtration to remove toxins from the blood.
Sterile non-pyrogenic replacement fluid is added to the blood either prior to or after it enters a hemodiafiltration cartridge. The replacement fluid replaces plasma water which is filtered across the semi-permeable membrane during the hemodiafiltration process. The advantage of hemodiafiltration over hemodialysis is the use of filtration in conjunction with diffusion to remove toxins. As a result of this combination, hemodiafiltration is more efficient at removing small molecules, e.g., creatinine and urea, as well as removing much greater quantities of middle range MW substances, by filtration.
Field of the Invention The present invention relates to hemodiafiltration devices and methods and, more particularly, to a new hemodiafiltration cartridge and its method of use.
Background of Invention Current treatment for End Stage Renal Disease (ESRD) essentially consists of hemodialysis process, wherein blood to be cleaned flows on one side of a semipermeable membrane and a physiologic solution, a dialysate, flows on the other side of the membrane,whereby toxins in the blood are transferred from one side to the other. The primary driving force in this treatment is diffusion. This process is generally effective in removing small Molecular Weight (MW) toxins such as urea and creatinine. However, this process is much less effective in removing middle range MW
substances, e.g., substances having a molecular weight higher than about 1 kDa, because of a low diffusion coefficient of such substances.
To a much lesser extent hemodiafiltration is used as a treatment modality. In hemodiafiltration, diffusion is combined with filtration to remove toxins from the blood.
Sterile non-pyrogenic replacement fluid is added to the blood either prior to or after it enters a hemodiafiltration cartridge. The replacement fluid replaces plasma water which is filtered across the semi-permeable membrane during the hemodiafiltration process. The advantage of hemodiafiltration over hemodialysis is the use of filtration in conjunction with diffusion to remove toxins. As a result of this combination, hemodiafiltration is more efficient at removing small molecules, e.g., creatinine and urea, as well as removing much greater quantities of middle range MW substances, by filtration.
State of the art designs for hemodiafiltration filters are substantially equivalent to those of high flux dialyzers. Such filters consist of bundles of hollow fibers in a cylindrical housing. During operation of the hemodiafiltration system, replacement fluid is injected into the blood either upstream (pre-dilution) or downstream (post-dilution) of the filter cartridge.
Diafiltration devices using pre-dilution or'post-dilution schemes have inherent efficiency limitations.
Pre-dilution schemes allow for relatively unlimited filtration, however, because the blood is diluted prior to reaching the filter, the overall mass transfer of solutes is decreased. Post-dilution schemes have the advantage of keeping blood concentrations high, resulting in more efficient diffusion and convection of solutes, however, the increased concentration of blood cells and the resultant higher blood viscosity during filtration, poses a limit on the amount of water that can be filtered.
Sununary of Invention It is an object of some aspects of the present invention to provide a hemodiafiltration cartridge that enables a higher toxin removal rate and higher toxin removal efficiency than that of prior art'hemodiafiltration devices. The present invention reduces and/or eliminates the above mentioned drawbacks of prior art hemodiafiltration devices by providing a scheme in which blood is diluted after it is partially, but not fully, diafiltered. The scheme of the present invention combines the benefits of pre-dilution schemes, e.g., high filtration rate, with the benefits of post dilution schemes, e.g., high diffusive and convective efficiencies. The device of the present invention may be adapted to operate in conjunction with a dual-stage hemodiafiltration machine, or a standard dialysis machine. using dual-stage hemodiafiltration, such as the machines described in PCT patent application No.
PCT/US99/17468 and in PCT patent application No. PCT/US99/25804, assigned to the assignee of the present application. Alternatively, by making appropriate alterations in a dual-stage device according to the present invention, e.g., by allowing direct flow of dialysate fluid between the two stages of the dual-stage device, the present invention may be adapted for use in conjunction with a standard dialysis machine using single stage diafiltration.
Therefore, the present invention concerns a dual-stage hemodiafiltration cartridge comprising:
a first hemodiafiltration stage including a first housing having first and second ends and first filtering elements disposed between the first and second ends, the first end being associated with a blood inlet which allows flow of blood into a blood-side of said first filtering elements and a first dialysate outlet which allows flow of dialysate out of a dialysate-side of said first filtering elements and the second end being associated with a first dialysate inlet which allows flow of dialysate into a dialysate-side of said first filtering elements;
a second hemodiafiltration stage including a second housing having third and fourth ends and second filtering elements disposed between the third and fourth ends, the fourth end being associated with a blood outlet which allows flow of blood out of a blood-side of said second filtering elements and a second dialysate inlet which allows flow of dialysate into a dialysate-side of said second filtering elements and the third end being associated with a second dialysate outlet which allows flow of dialysate out of the dialysate-side of said second filtering elements; and an inter-stage connector connected to the second end of the first housing and to the third end of the second 3a housing and adapted to allow flow of blood from the blood side of the first filtering elements to the blood-side of the second filtering elements and flow of dialysate fluid there through from the second stage to the first, wherein said inter-stage connector has a header space in communication with the blood-side of the first filtering elements and with the blood-side of the second filtering elements, the inter-stage connector having a substitution-fluid inlet which allows flow of substitution fluid into said header space thereby to dilute the blood in said header space.
A hemodiafiltration cartridge in accordance with the present invention has blood and dialysate inlet and outlet ports. The cartridge of the present invention includes two housings, for example, two cylindrical housings, corresponding to two hemodiafiltration stages, wherein the first stage has a blood inlet and a dialysate outlet, and the second stage has a blood outlet and dialysate inlet.
In an embodiment of the present invention, the blood inlet and outlet ports and the dialysate inlet and outlet ports are located on one side, e.g., at the top, of the cartridge. Each of the two hemodiafiltration stages of the present invention may contain longitudinal bundles of high flux, semi-permeable, hollow fibers, which may be sealed off from the dialysate compartments at each end by a potting compound such as polyurethane. The blood inlet may include a header member that may be attached to a casing of the cartridge, at the fiber ends.
In one embodiment, the two stages are produced separately and then assembled together. Alternatively, the two stages may be manufactured as a single unit. The method of production does not affect the resultant dual-stage cartridge.
In an embodiment of the present invention, the cartridge includes two additional ports, preferably at the CA 02395701 2002-06-25 pgNS O O / 35717 tPEAll1S ~ 1 OCT 2001 second end, e.g., the bottom end, of the cartridge. One of these additional ports may be a substitution fluid inlet where sterile replacement fluid is mixed with the blood.
This mixing may take place in a common header space, between the first and second stages, where the blood exits the hollow fibers of the first stage and enters the fibers of the second stage.
The other additional port may be an inter-dialysate port, for example, a dual aperture port, which directs dialysate fluid exiting the second stage of the ..i cartridge to cycle through the controlling machine, where the flow rate of the dialysate may be metered, and returns the dialysate to the first stage. While the total level of filtration of the cartridge is generally controlled by the dialysate inlet and outlet rates, the inter-dialysate port enables control of the individual filtration rates of the two cartridge stages. This port may also enable modification of the dialysate flow rate or dialysate composition between the two stages. In an alternative embodiment of the invention, the dialysate fluid exiting the second stage may be directed to flow directly into the first stage, e.g., by providing an aperture-connecting cap to the dual-aperture port.
Brief Description of the Drawings Fig. 1B is a schematic, cross-sectional, top view, illustration of the dual stage hemodiafiltration cartridge of Fig. 1A, taken along section line 1B-1B;
Fig. 2A is a schematic, cross-sectional, front view, illustration of a dual stage hemodiafiltration cartridge in accordance with another preferred embodiment of the present invention;
AMENDED SHEET
CA 02395701 2002-06-25 PUMS O 0 135 7 17, IPEAAuS 5% 1 ocT 2001 Fig. 2B is a schematic, cross-sectional, top view, illustration of the dual stage hemodiafiltration cartridge of Fig. 2A, taken along section line 2B-2B;
Fig. 2C is a schematic, cross-sectional, side view, 5 illustration of the dual stage hemodiafiltration cartridge of Fig. 2A;
Fig. 3A is a schematic, cross-sectional, top view, illustration of the dual stage hemodiafiltration cartridge of Fig. 1A, taken along section lines 1B-1B, showing connection of an inter-dialysate port of the cartridge to a hemodiafiltration machine; and Fig. 3B is a schematic, cross-sectional, top view, illustration of the dual stage hemodiafiltration cartridge of Fig. 1A, taken along section lines 1.B-1B, showing connection of a inter-dialysate port of the cartridge to an aperture-connecting cap.
Detailed Description of Preferred Embodi.ments Reference is made to Figs. lA and 1B which schematically illustrate a cross-sectional front view and a cross-sectional top view, respectively, of a dual stage hemodiafiltration cartridge 10 in accordance with one preferred embodiment of the present invention. Cartridge 10 includes a first stage 52 and a second stage 53. Stages 52 and 53 preferably include generally cylindrical housings, 62 and 63, respectively, of a rigid plastic material.
Housings 62 and 63 contain longitudinal bundles of semipermeable hollow fibers 54, as are known in the art.
The semipermeable fibers serve as a means for transferring the toxins which are being filtered from the blood.
In an embodiment of the present invention, cartridge 10 is adapted to operate in conjunction with a dual stage-hemodiafiltration machine, or a standard dialysis machine using dual-stage hemodiafiltration, such as the machines described in PCT patent application No. PCT/US99/17468 AMENDED SHEET
Diafiltration devices using pre-dilution or'post-dilution schemes have inherent efficiency limitations.
Pre-dilution schemes allow for relatively unlimited filtration, however, because the blood is diluted prior to reaching the filter, the overall mass transfer of solutes is decreased. Post-dilution schemes have the advantage of keeping blood concentrations high, resulting in more efficient diffusion and convection of solutes, however, the increased concentration of blood cells and the resultant higher blood viscosity during filtration, poses a limit on the amount of water that can be filtered.
Sununary of Invention It is an object of some aspects of the present invention to provide a hemodiafiltration cartridge that enables a higher toxin removal rate and higher toxin removal efficiency than that of prior art'hemodiafiltration devices. The present invention reduces and/or eliminates the above mentioned drawbacks of prior art hemodiafiltration devices by providing a scheme in which blood is diluted after it is partially, but not fully, diafiltered. The scheme of the present invention combines the benefits of pre-dilution schemes, e.g., high filtration rate, with the benefits of post dilution schemes, e.g., high diffusive and convective efficiencies. The device of the present invention may be adapted to operate in conjunction with a dual-stage hemodiafiltration machine, or a standard dialysis machine. using dual-stage hemodiafiltration, such as the machines described in PCT patent application No.
PCT/US99/17468 and in PCT patent application No. PCT/US99/25804, assigned to the assignee of the present application. Alternatively, by making appropriate alterations in a dual-stage device according to the present invention, e.g., by allowing direct flow of dialysate fluid between the two stages of the dual-stage device, the present invention may be adapted for use in conjunction with a standard dialysis machine using single stage diafiltration.
Therefore, the present invention concerns a dual-stage hemodiafiltration cartridge comprising:
a first hemodiafiltration stage including a first housing having first and second ends and first filtering elements disposed between the first and second ends, the first end being associated with a blood inlet which allows flow of blood into a blood-side of said first filtering elements and a first dialysate outlet which allows flow of dialysate out of a dialysate-side of said first filtering elements and the second end being associated with a first dialysate inlet which allows flow of dialysate into a dialysate-side of said first filtering elements;
a second hemodiafiltration stage including a second housing having third and fourth ends and second filtering elements disposed between the third and fourth ends, the fourth end being associated with a blood outlet which allows flow of blood out of a blood-side of said second filtering elements and a second dialysate inlet which allows flow of dialysate into a dialysate-side of said second filtering elements and the third end being associated with a second dialysate outlet which allows flow of dialysate out of the dialysate-side of said second filtering elements; and an inter-stage connector connected to the second end of the first housing and to the third end of the second 3a housing and adapted to allow flow of blood from the blood side of the first filtering elements to the blood-side of the second filtering elements and flow of dialysate fluid there through from the second stage to the first, wherein said inter-stage connector has a header space in communication with the blood-side of the first filtering elements and with the blood-side of the second filtering elements, the inter-stage connector having a substitution-fluid inlet which allows flow of substitution fluid into said header space thereby to dilute the blood in said header space.
A hemodiafiltration cartridge in accordance with the present invention has blood and dialysate inlet and outlet ports. The cartridge of the present invention includes two housings, for example, two cylindrical housings, corresponding to two hemodiafiltration stages, wherein the first stage has a blood inlet and a dialysate outlet, and the second stage has a blood outlet and dialysate inlet.
In an embodiment of the present invention, the blood inlet and outlet ports and the dialysate inlet and outlet ports are located on one side, e.g., at the top, of the cartridge. Each of the two hemodiafiltration stages of the present invention may contain longitudinal bundles of high flux, semi-permeable, hollow fibers, which may be sealed off from the dialysate compartments at each end by a potting compound such as polyurethane. The blood inlet may include a header member that may be attached to a casing of the cartridge, at the fiber ends.
In one embodiment, the two stages are produced separately and then assembled together. Alternatively, the two stages may be manufactured as a single unit. The method of production does not affect the resultant dual-stage cartridge.
In an embodiment of the present invention, the cartridge includes two additional ports, preferably at the CA 02395701 2002-06-25 pgNS O O / 35717 tPEAll1S ~ 1 OCT 2001 second end, e.g., the bottom end, of the cartridge. One of these additional ports may be a substitution fluid inlet where sterile replacement fluid is mixed with the blood.
This mixing may take place in a common header space, between the first and second stages, where the blood exits the hollow fibers of the first stage and enters the fibers of the second stage.
The other additional port may be an inter-dialysate port, for example, a dual aperture port, which directs dialysate fluid exiting the second stage of the ..i cartridge to cycle through the controlling machine, where the flow rate of the dialysate may be metered, and returns the dialysate to the first stage. While the total level of filtration of the cartridge is generally controlled by the dialysate inlet and outlet rates, the inter-dialysate port enables control of the individual filtration rates of the two cartridge stages. This port may also enable modification of the dialysate flow rate or dialysate composition between the two stages. In an alternative embodiment of the invention, the dialysate fluid exiting the second stage may be directed to flow directly into the first stage, e.g., by providing an aperture-connecting cap to the dual-aperture port.
Brief Description of the Drawings Fig. 1B is a schematic, cross-sectional, top view, illustration of the dual stage hemodiafiltration cartridge of Fig. 1A, taken along section line 1B-1B;
Fig. 2A is a schematic, cross-sectional, front view, illustration of a dual stage hemodiafiltration cartridge in accordance with another preferred embodiment of the present invention;
AMENDED SHEET
CA 02395701 2002-06-25 PUMS O 0 135 7 17, IPEAAuS 5% 1 ocT 2001 Fig. 2B is a schematic, cross-sectional, top view, illustration of the dual stage hemodiafiltration cartridge of Fig. 2A, taken along section line 2B-2B;
Fig. 2C is a schematic, cross-sectional, side view, 5 illustration of the dual stage hemodiafiltration cartridge of Fig. 2A;
Fig. 3A is a schematic, cross-sectional, top view, illustration of the dual stage hemodiafiltration cartridge of Fig. 1A, taken along section lines 1B-1B, showing connection of an inter-dialysate port of the cartridge to a hemodiafiltration machine; and Fig. 3B is a schematic, cross-sectional, top view, illustration of the dual stage hemodiafiltration cartridge of Fig. 1A, taken along section lines 1.B-1B, showing connection of a inter-dialysate port of the cartridge to an aperture-connecting cap.
Detailed Description of Preferred Embodi.ments Reference is made to Figs. lA and 1B which schematically illustrate a cross-sectional front view and a cross-sectional top view, respectively, of a dual stage hemodiafiltration cartridge 10 in accordance with one preferred embodiment of the present invention. Cartridge 10 includes a first stage 52 and a second stage 53. Stages 52 and 53 preferably include generally cylindrical housings, 62 and 63, respectively, of a rigid plastic material.
Housings 62 and 63 contain longitudinal bundles of semipermeable hollow fibers 54, as are known in the art.
The semipermeable fibers serve as a means for transferring the toxins which are being filtered from the blood.
In an embodiment of the present invention, cartridge 10 is adapted to operate in conjunction with a dual stage-hemodiafiltration machine, or a standard dialysis machine using dual-stage hemodiafiltration, such as the machines described in PCT patent application No. PCT/US99/17468 AMENDED SHEET
and/or in PCT patent application No. PCT/US99/25804.
During operation, blood transferred from the patient, via a blood pump of a dual stage hemodiafiltration machine, enters first stage 52 of cartridge 10 through an inlet port 55 which is preferably formed in a header cap 56 mounted on an inlet end of housing 62. Cap 56 defines an inner header space 57 which may be separated from the rest of the cartridge by a potting compound 58, which forms a seal around the outside surfaces of hollow fibers 54. Header cap 56 may be removable and, in'such case, header space 57 is preferably sealed from the external environment by a sealing member, such as an 0-ring 59.
As blood traverses down the insides of fibers 54, along a main filtration space 60 of first stage 52, the outsides of fibers 54 are immersed in dialysate. This results in first stage hemodiafiltration of toxins, i.e., both filtration and diffusion, which takes place along the entire length of fibers 54 within filtration space 60. In an embodiment of the present invention, a significant pbrtion, e.g., approximately 40%-60%, of the plasma water is filtered as the blood flows through first stage 52. The partly hemodiafiltered blood exiting first stage 52 enters an inter-stage header space 11 associated with another end of housing 62. The blood entering inter-stage header space 11 is in a hemoconcentrated state, i.e., the level of hematocrit in the blood is increased. In accordance with an embodiment of the invention, filtration space 60 of first stage 52 and a filtration space 61 of second stage 53 are separated from header 11, for example, by a potting compound 68, in analogy to the separation described above with reference to header space 57 and potting compound 58.
Inter-stage header space 11, which acts as a transition stage for blood exiting first stage 52 and entering second stage 53, is defined by a stage connector 12 which is preferably made from rigid plastic material and is attached to both the outlet end of first stage 52 and the inlet end of second stage 53, for example, by bonding or welding. Stage connector 12 encloses and defines header space 11 as well as two separate dialysate spaces, 19 and 69. A removable inter-stage header cap 13 having an inlet port 15 is attached to stage connector 12. Header space 11 may be sealed from the external environment by a sealing member, for example,~an 0-ring 14.
The blood residing in header space 11 prior to entering second stage 53, is diluted with a physiological sterile solution that enters cartridge 10 via header inlet port 15. The sterile solution may be produced continuously, in an "on-line" manner, or provided from reservoirs, e.g., saline bags, as are known in the art. The blood in inter-stage space 11 is hemodiluted, i.e., the blood hematocrit level is decreased. The hemodiluted blood is then carried by fibers 64 disposed in second stage 53, in a manner similar to that described above with reference to first stage 52. At second stage 53 the blood undergoes further hemodiafiltration. The outlet end of second stage 53 is capped with a header cap 66, defining a header space 67 therein, having a blood outlet port 16, in analogy with the above description of header cap 56.
In an embodiment of the present invention, the blood is diafiltered by cartridge 10 at such a rate so that upon exiting second stage 53, via a blood outlet port 16, the blood hematocrit level is substantially the same as that of the blood entering first stage 52. As in standard hemodialysis processes, small -changes in the blood hematocrit level may be required in order to control the net ultrafiltration, as may be necessary to maintain patient fluid balance.
As in standard dialysis processes, the dialysate in the present invention is perfused through cartridge 10 in a"counter- current" direction relative to the flow of blood. The dialysate enters second stage 53 via a dialysate inlet 17. A flow disperser 18 ensures that the dialysate will better perfuse the fiber bundle in second stage 53. An inter-dialysate port 20 is preferably associated with dialysate exit region 19 of second stage 53 and with dialysate inlet region 69 of first stage 52.Inter-dialysate port 20 (shown more clearly in Fig. 1B) is preferably a dual-aperture port including a second stage outlet 21 and a first stage inlet 22.
Reference is now made also to Fig. 3A which schematically illustrates a cross-sectional side view of cartridge 10, showing connection of inter-dialysate port 20 to a hemodiafiltration machine 71, and to Fig. 3B which schematically illustrates a cross-sectional side view of cartridge 10, showing connection of inter-dialysate port 20 to an aperture-connecting cap 73. Machine 71 is preferably a dual-stage hemodiafiltration machine as described. As shown in Fig. 3A, inter-dialysate port 20 may be connected to machine 71 using a dual-aperture connector 24 which is adapted to fit connections 72 on hemodiafiltration machine 71.
In an embodiment of the present invention, hemodiafiltration machine 71 is adapted to monitor the flow and/or dialysate pressures between the first and second stages of cartridge 10. For example, the hemodiafiltration machine may include an inter-dialysate pump (not shown), which may be used to monitor the flow between the first and second stages of cartridge 10 and/or the relative dialysate pressures of the two stages. It should be appreciated, however, that machine 71 may include any other suitable mechanisms, as are know in the art, for controlling dialysate pressure and/or flow. The monitoring of inter-stage flow and/or pressure, enables control of the level of filtration in each of the first and second stages to optimize process efficiency.
Hemodiafiltration machine 71 may also be adapted to monitor and/or control other parameters of the dialysate fluid, between the first and second stages, as described in PCT application No. PCT/US99/17468 and in PCT application No. PCT/US99/25804. For example, the composition and/or salt concentration of the dialysate may be modified between the two stages as described in PCT/US99/25804.
After passing through both hemodiafiltration stages, either directly or via machine 71, as described above, the used dialysate exits cartridge 10 via a dialysate outlet 23 of first stage 52.
Blood inlet and outlet ports 55 and 16, respectively, may be associated with locking connectors, as are known in the art, designed to mate with standard bloodlines.
Dialysate inlet port 17 and dialysate outlet port 23 may be associated with standard Hansen connectors, as are know in the art. Substitution fluid inlet port 15 may be associated with a standard luer, e.g., a 6% tapered connector as specified in the ISO 594, adapted to accommodate an IV set, as is known in the art.
To accommodate a dialyzer reuse machines having blood inlet and outlet ports, as are know in the art, substitution fluid inlet port 15 may be capped during reuse. The use of removable header caps 56, 66 and 13, as described above, enables tubesheet cleaning during reuse.
Additionally, inter-dialysate port 20 may be fitted with the aperture-connecting cap 73 (Fig. 3B) which allows direct dialysate flow from second stage 53 to first stage 52. Cap 73 seals inter-dialysate port 20 from the external environment while allowing flow of dialysate between dialysate outlet 21 of stage 53 and dialysate inlet 22 of stage 52. Such sealing may be useful during reuse, whereby a dialyzer reuse machine may communicate with cartridge 10 as if it were a standard dialyzer. By allowing direct dialysate flow between the first and second stages, as described above, cartridge 10 may be used in conjunction with a standard dialysis machine, i.e., a dialysis machine 5 designed to operate with a single-stage dialyzer.
A thread or any other suitable locking mechanism, as is known in the art, may be provided on the exterior surface of outlet port 24 to enable tight sealing of port 24 with either the dialysis machine connector 72 or 10 aperture-connecting cap 73.
In the embodiment of Figs. lA and 1B, the first and second stages may be manufactured separately and assembled together prior to packaging. Each of housings 62 and 63 is stuffed with a fiber bundle as described above, and may be centrifugally potted as is known in the art. A potting compound, for example, polyurethane resin, may be introduced into first stage 52 via dialysate outlet port 23. At the other end of first stage 52, the potting compound may be introduced via a dedicated potting port 25 which is analogous to the opening of a second dialysate port in conventional dialyzers. The assembly procedure for second stage 53 is analogous to that of first stage 52.
Thus, standard potting techniques and equipment may be used in the assembly of the cartridge of the present invention.
To complete the assembly process, the potted ends of the fibers are trimmed to form a smooth tubesheet of open fibers, and the two stages are assembled into a single unit. The final assembly may be preformed as follows. The two stages are locked together, for example, using a "tongue in groove" type bond or weld 26, including a male portion 27 on housing 62 and a female portions 28 on housing 53, or vice versa. This arrangement keeps the housings from being twisted out of alignment. Stage connector 12 may be bonded or welded to the two housings, as mentioned above.
During operation, blood transferred from the patient, via a blood pump of a dual stage hemodiafiltration machine, enters first stage 52 of cartridge 10 through an inlet port 55 which is preferably formed in a header cap 56 mounted on an inlet end of housing 62. Cap 56 defines an inner header space 57 which may be separated from the rest of the cartridge by a potting compound 58, which forms a seal around the outside surfaces of hollow fibers 54. Header cap 56 may be removable and, in'such case, header space 57 is preferably sealed from the external environment by a sealing member, such as an 0-ring 59.
As blood traverses down the insides of fibers 54, along a main filtration space 60 of first stage 52, the outsides of fibers 54 are immersed in dialysate. This results in first stage hemodiafiltration of toxins, i.e., both filtration and diffusion, which takes place along the entire length of fibers 54 within filtration space 60. In an embodiment of the present invention, a significant pbrtion, e.g., approximately 40%-60%, of the plasma water is filtered as the blood flows through first stage 52. The partly hemodiafiltered blood exiting first stage 52 enters an inter-stage header space 11 associated with another end of housing 62. The blood entering inter-stage header space 11 is in a hemoconcentrated state, i.e., the level of hematocrit in the blood is increased. In accordance with an embodiment of the invention, filtration space 60 of first stage 52 and a filtration space 61 of second stage 53 are separated from header 11, for example, by a potting compound 68, in analogy to the separation described above with reference to header space 57 and potting compound 58.
Inter-stage header space 11, which acts as a transition stage for blood exiting first stage 52 and entering second stage 53, is defined by a stage connector 12 which is preferably made from rigid plastic material and is attached to both the outlet end of first stage 52 and the inlet end of second stage 53, for example, by bonding or welding. Stage connector 12 encloses and defines header space 11 as well as two separate dialysate spaces, 19 and 69. A removable inter-stage header cap 13 having an inlet port 15 is attached to stage connector 12. Header space 11 may be sealed from the external environment by a sealing member, for example,~an 0-ring 14.
The blood residing in header space 11 prior to entering second stage 53, is diluted with a physiological sterile solution that enters cartridge 10 via header inlet port 15. The sterile solution may be produced continuously, in an "on-line" manner, or provided from reservoirs, e.g., saline bags, as are known in the art. The blood in inter-stage space 11 is hemodiluted, i.e., the blood hematocrit level is decreased. The hemodiluted blood is then carried by fibers 64 disposed in second stage 53, in a manner similar to that described above with reference to first stage 52. At second stage 53 the blood undergoes further hemodiafiltration. The outlet end of second stage 53 is capped with a header cap 66, defining a header space 67 therein, having a blood outlet port 16, in analogy with the above description of header cap 56.
In an embodiment of the present invention, the blood is diafiltered by cartridge 10 at such a rate so that upon exiting second stage 53, via a blood outlet port 16, the blood hematocrit level is substantially the same as that of the blood entering first stage 52. As in standard hemodialysis processes, small -changes in the blood hematocrit level may be required in order to control the net ultrafiltration, as may be necessary to maintain patient fluid balance.
As in standard dialysis processes, the dialysate in the present invention is perfused through cartridge 10 in a"counter- current" direction relative to the flow of blood. The dialysate enters second stage 53 via a dialysate inlet 17. A flow disperser 18 ensures that the dialysate will better perfuse the fiber bundle in second stage 53. An inter-dialysate port 20 is preferably associated with dialysate exit region 19 of second stage 53 and with dialysate inlet region 69 of first stage 52.Inter-dialysate port 20 (shown more clearly in Fig. 1B) is preferably a dual-aperture port including a second stage outlet 21 and a first stage inlet 22.
Reference is now made also to Fig. 3A which schematically illustrates a cross-sectional side view of cartridge 10, showing connection of inter-dialysate port 20 to a hemodiafiltration machine 71, and to Fig. 3B which schematically illustrates a cross-sectional side view of cartridge 10, showing connection of inter-dialysate port 20 to an aperture-connecting cap 73. Machine 71 is preferably a dual-stage hemodiafiltration machine as described. As shown in Fig. 3A, inter-dialysate port 20 may be connected to machine 71 using a dual-aperture connector 24 which is adapted to fit connections 72 on hemodiafiltration machine 71.
In an embodiment of the present invention, hemodiafiltration machine 71 is adapted to monitor the flow and/or dialysate pressures between the first and second stages of cartridge 10. For example, the hemodiafiltration machine may include an inter-dialysate pump (not shown), which may be used to monitor the flow between the first and second stages of cartridge 10 and/or the relative dialysate pressures of the two stages. It should be appreciated, however, that machine 71 may include any other suitable mechanisms, as are know in the art, for controlling dialysate pressure and/or flow. The monitoring of inter-stage flow and/or pressure, enables control of the level of filtration in each of the first and second stages to optimize process efficiency.
Hemodiafiltration machine 71 may also be adapted to monitor and/or control other parameters of the dialysate fluid, between the first and second stages, as described in PCT application No. PCT/US99/17468 and in PCT application No. PCT/US99/25804. For example, the composition and/or salt concentration of the dialysate may be modified between the two stages as described in PCT/US99/25804.
After passing through both hemodiafiltration stages, either directly or via machine 71, as described above, the used dialysate exits cartridge 10 via a dialysate outlet 23 of first stage 52.
Blood inlet and outlet ports 55 and 16, respectively, may be associated with locking connectors, as are known in the art, designed to mate with standard bloodlines.
Dialysate inlet port 17 and dialysate outlet port 23 may be associated with standard Hansen connectors, as are know in the art. Substitution fluid inlet port 15 may be associated with a standard luer, e.g., a 6% tapered connector as specified in the ISO 594, adapted to accommodate an IV set, as is known in the art.
To accommodate a dialyzer reuse machines having blood inlet and outlet ports, as are know in the art, substitution fluid inlet port 15 may be capped during reuse. The use of removable header caps 56, 66 and 13, as described above, enables tubesheet cleaning during reuse.
Additionally, inter-dialysate port 20 may be fitted with the aperture-connecting cap 73 (Fig. 3B) which allows direct dialysate flow from second stage 53 to first stage 52. Cap 73 seals inter-dialysate port 20 from the external environment while allowing flow of dialysate between dialysate outlet 21 of stage 53 and dialysate inlet 22 of stage 52. Such sealing may be useful during reuse, whereby a dialyzer reuse machine may communicate with cartridge 10 as if it were a standard dialyzer. By allowing direct dialysate flow between the first and second stages, as described above, cartridge 10 may be used in conjunction with a standard dialysis machine, i.e., a dialysis machine 5 designed to operate with a single-stage dialyzer.
A thread or any other suitable locking mechanism, as is known in the art, may be provided on the exterior surface of outlet port 24 to enable tight sealing of port 24 with either the dialysis machine connector 72 or 10 aperture-connecting cap 73.
In the embodiment of Figs. lA and 1B, the first and second stages may be manufactured separately and assembled together prior to packaging. Each of housings 62 and 63 is stuffed with a fiber bundle as described above, and may be centrifugally potted as is known in the art. A potting compound, for example, polyurethane resin, may be introduced into first stage 52 via dialysate outlet port 23. At the other end of first stage 52, the potting compound may be introduced via a dedicated potting port 25 which is analogous to the opening of a second dialysate port in conventional dialyzers. The assembly procedure for second stage 53 is analogous to that of first stage 52.
Thus, standard potting techniques and equipment may be used in the assembly of the cartridge of the present invention.
To complete the assembly process, the potted ends of the fibers are trimmed to form a smooth tubesheet of open fibers, and the two stages are assembled into a single unit. The final assembly may be preformed as follows. The two stages are locked together, for example, using a "tongue in groove" type bond or weld 26, including a male portion 27 on housing 62 and a female portions 28 on housing 53, or vice versa. This arrangement keeps the housings from being twisted out of alignment. Stage connector 12 may be bonded or welded to the two housings, as mentioned above.
Stage connector 12 may includes inter-dialysate port 20 as well as a mating portion 29 for connecting inter-stage header cap 15. Connector 12 may be circumferentially welded or bonded to housings 62 and 63 at several locations.
A first bond may be formed along the flat ends of the outer rims 30 of housings 62 and 63, where the tubesheet may be encased. This bond seals the blood sides of both stages 52 and 53 from the external environment, but.allows free flow through the inter-stage header space 11 between stages 52 and 53. The bond is preferably formed along the entire rim of each housing, including a common central mating portion 31.
A second weld or bond may be formed along external flanges 32 of housings 62 and 63. This bond seals the dialysate potting ports from the external environment and forces all the inter-dialysate flow to go through the inter-dialysate port. Here too there is a common central bond 33 that effectively separates the dialysate compartments of the two stages.
Stage connector 12 is preferably designed such that dialysate may flow out of potting port 25 into an external space 34 around the outside of the stage housings, as well as to the central area where inter-dialysate port 20 is located.
Reference is now made to Figs. 2A-2C which schematically illustrate a cross-sectional front, a cross-sectional top view and a cross-sectional side-view, respectively, of a dual stage hemodiafiltration cartridge 110 in accordance with another preferred embodiment of the present invention. Most of the elements of cartridge 110, as shown in the embodiment of Figs. 2A-2C, as well as the features and functions of such elements, are substantially the same as described above with reference to the embodiment of Figs. 1A and 1B. Cartridge 110 is mounted to a hemodiafiltration machine in the manner described above with reference to the embodiment of Figs. 1A and 1B.
The difference between the two embodiments is primarily in the structure and assembly of the inter-stage section. In the embodiment of Figs. 2A-2C, instead of bonding two separately formed cylindrical housings, a dual-housing structure 35 is molded as a single unit, including a first stage housing 162 and a second stage housing 163, for a first hemodiafiltration stage 152 and a second hemodiafiltration stage 153, respectively. This obviates the need for an inter-stage connector and interlocking web, as described above with reference to the embodiment of Figs. 1A and 1B. These elements of the preceding embodiments are replaced by a common inter-stage molded encasement 37 and a molded web 36, respectively.
Molded structure 35 is preferably formed with an integral, generally circular, end portion 38 which accommodates a removable inter-stage header cap 39. In this arrangement, the entire cross-section of encasement 37 is filled with a potting compound 40, thereby to seal the blood side of the fibers bundled in cartridge 110 from the dialysate side of the fibers. A dual-aperture inter-dialysate port 120, shown particularly in Fig. 2B, is used in this embodiment substantially in the manner described above with reference to port 20 of Fig. 1B. However, in this embodiment, the dialysate of first stage 152 is separated from the dialysate of second stage 153 by a rib member 41 across the entire diameter of inter-stage encasement 37. Rib 41 may be molded to one end 42 of web 36 and sealed to the potting compound at the other end 43.
It will be appreciated by persons skilled in the art that the present invention is not limited to the embodiments described thus far with reference to the accompanying drawing. Rather the present invention is limited only by the following claims.
A first bond may be formed along the flat ends of the outer rims 30 of housings 62 and 63, where the tubesheet may be encased. This bond seals the blood sides of both stages 52 and 53 from the external environment, but.allows free flow through the inter-stage header space 11 between stages 52 and 53. The bond is preferably formed along the entire rim of each housing, including a common central mating portion 31.
A second weld or bond may be formed along external flanges 32 of housings 62 and 63. This bond seals the dialysate potting ports from the external environment and forces all the inter-dialysate flow to go through the inter-dialysate port. Here too there is a common central bond 33 that effectively separates the dialysate compartments of the two stages.
Stage connector 12 is preferably designed such that dialysate may flow out of potting port 25 into an external space 34 around the outside of the stage housings, as well as to the central area where inter-dialysate port 20 is located.
Reference is now made to Figs. 2A-2C which schematically illustrate a cross-sectional front, a cross-sectional top view and a cross-sectional side-view, respectively, of a dual stage hemodiafiltration cartridge 110 in accordance with another preferred embodiment of the present invention. Most of the elements of cartridge 110, as shown in the embodiment of Figs. 2A-2C, as well as the features and functions of such elements, are substantially the same as described above with reference to the embodiment of Figs. 1A and 1B. Cartridge 110 is mounted to a hemodiafiltration machine in the manner described above with reference to the embodiment of Figs. 1A and 1B.
The difference between the two embodiments is primarily in the structure and assembly of the inter-stage section. In the embodiment of Figs. 2A-2C, instead of bonding two separately formed cylindrical housings, a dual-housing structure 35 is molded as a single unit, including a first stage housing 162 and a second stage housing 163, for a first hemodiafiltration stage 152 and a second hemodiafiltration stage 153, respectively. This obviates the need for an inter-stage connector and interlocking web, as described above with reference to the embodiment of Figs. 1A and 1B. These elements of the preceding embodiments are replaced by a common inter-stage molded encasement 37 and a molded web 36, respectively.
Molded structure 35 is preferably formed with an integral, generally circular, end portion 38 which accommodates a removable inter-stage header cap 39. In this arrangement, the entire cross-section of encasement 37 is filled with a potting compound 40, thereby to seal the blood side of the fibers bundled in cartridge 110 from the dialysate side of the fibers. A dual-aperture inter-dialysate port 120, shown particularly in Fig. 2B, is used in this embodiment substantially in the manner described above with reference to port 20 of Fig. 1B. However, in this embodiment, the dialysate of first stage 152 is separated from the dialysate of second stage 153 by a rib member 41 across the entire diameter of inter-stage encasement 37. Rib 41 may be molded to one end 42 of web 36 and sealed to the potting compound at the other end 43.
It will be appreciated by persons skilled in the art that the present invention is not limited to the embodiments described thus far with reference to the accompanying drawing. Rather the present invention is limited only by the following claims.
Claims (19)
1. A dual-stage hemodiafiltration cartridge comprising:
a first hemodiafiltration stage including a first housing having first and second ends and first filtering elements disposed between the first and second ends, the first end being associated with a blood inlet which allows flow of blood into a blood-side of said first filtering elements and a first dialysate outlet which allows flow of dialysate out of a dialysate-side of said first filtering elements and the second end being associated with a first dialysate inlet which allows flow of dialysate into a dialysate-side of said first filtering elements;
a second hemodiafiltration stage including a second housing having third and fourth ends and second filtering elements disposed between the third and fourth ends, the fourth end being associated with a blood outlet which allows flow of blood out of a blood-side of said second filtering elements and a second dialysate inlet which allows flow of dialysate into a dialysate-side of said second filtering elements and the third end being associated with a second dialysate outlet which allows flow of dialysate out of the dialysate-side of said second filtering elements; and an inter-stage connector connected to the second end of the first housing and to the third end of the second housing and adapted to allow flow of blood from the blood side of the first filtering elements to the blood-side of the second filtering elements and flow of dialysate fluid there through from the second stage to the first, wherein said inter-stage connector has a header space in communication with the blood-side of the first filtering elements and with the blood-side of the second filtering elements, the inter-stage connector having a substitution-fluid inlet which allows flow of substitution fluid into said header space thereby to dilute the blood in said header space.
a first hemodiafiltration stage including a first housing having first and second ends and first filtering elements disposed between the first and second ends, the first end being associated with a blood inlet which allows flow of blood into a blood-side of said first filtering elements and a first dialysate outlet which allows flow of dialysate out of a dialysate-side of said first filtering elements and the second end being associated with a first dialysate inlet which allows flow of dialysate into a dialysate-side of said first filtering elements;
a second hemodiafiltration stage including a second housing having third and fourth ends and second filtering elements disposed between the third and fourth ends, the fourth end being associated with a blood outlet which allows flow of blood out of a blood-side of said second filtering elements and a second dialysate inlet which allows flow of dialysate into a dialysate-side of said second filtering elements and the third end being associated with a second dialysate outlet which allows flow of dialysate out of the dialysate-side of said second filtering elements; and an inter-stage connector connected to the second end of the first housing and to the third end of the second housing and adapted to allow flow of blood from the blood side of the first filtering elements to the blood-side of the second filtering elements and flow of dialysate fluid there through from the second stage to the first, wherein said inter-stage connector has a header space in communication with the blood-side of the first filtering elements and with the blood-side of the second filtering elements, the inter-stage connector having a substitution-fluid inlet which allows flow of substitution fluid into said header space thereby to dilute the blood in said header space.
2. A dual-stage hemodiafiltration cartridge according to claim 1 wherein said inter-stage connector comprises an inter-dialysate port including said first dialysate inlet and said second dialysate outlet.
3. A dual-stage hemodiafiltration cartridge according to claim 2 comprising an inter-aperture cap mounted on said inter-dialysate port and structured to allow flow of dialysate directly from the second dialysate outlet to the first dialysate inlet.
4. A hemodiafiltration system comprising:
a dual-stage hemodiafiltration cartridge according to claim 1; and a control mechanism adapted to receive dialysate from the second dialysate outlet and to supply dialysate to the first dialysate inlet, wherein said control mechanism controls the relative toxin removal rates of said first and second hemodiafiltration stages.
a dual-stage hemodiafiltration cartridge according to claim 1; and a control mechanism adapted to receive dialysate from the second dialysate outlet and to supply dialysate to the first dialysate inlet, wherein said control mechanism controls the relative toxin removal rates of said first and second hemodiafiltration stages.
5. A dual-stage hemodiafiltration cartridge according to claim 1, wherein said first and second housings are arranged parallel to one another with said first end spaced proximately from said fourth end such that the blood flows in a first direction in said first stage and in a second direction in said second stage, said first direction being opposite to said second direction.
6. A dual-stage hemodiafiltration cartridge comprising:
a first hemodiafiltration stage including a first housing having first and second ends;
at least one first filtering element disposed between said first and second ends of said first housing, said first end having a blood inlet which communicates with a blood-side of said at least one first filtering element and a first dialysate outlet which is in fluid communication with a dialysate-side of said at least one first filtering element, said second end of said first housing having a first dialysate inlet which admits dialysate into said dialysate-side of said at least one first filtering element;
a second hemodiafiltration stage including a second housing having third and fourth ends;
at least one second filtering element disposed between said third and fourth ends of said second housing, said fourth end having a blood outlet for passage of blood out of a blood-side of said at least one second filtering element and a second dialysate inlet which is in fluid communication with a dialysate-side of said at least one second filtering element, said third end having a second dialysate outlet for discharge of dialysate from said_dialysate-side of said at least one second filtering element; and a connector connected to said second end of said first housing and to said third end of said second housing for the passage of blood from the blood-side of said at least one first filtering element, said connector having a fluid inlet for receiving substitution fluid which mixes with the blood from said first stage before the blood flows to said blood-side of said at least one second filtering element of said second stage, said connector conducting the dialysate from said second stage to said first stage.
a first hemodiafiltration stage including a first housing having first and second ends;
at least one first filtering element disposed between said first and second ends of said first housing, said first end having a blood inlet which communicates with a blood-side of said at least one first filtering element and a first dialysate outlet which is in fluid communication with a dialysate-side of said at least one first filtering element, said second end of said first housing having a first dialysate inlet which admits dialysate into said dialysate-side of said at least one first filtering element;
a second hemodiafiltration stage including a second housing having third and fourth ends;
at least one second filtering element disposed between said third and fourth ends of said second housing, said fourth end having a blood outlet for passage of blood out of a blood-side of said at least one second filtering element and a second dialysate inlet which is in fluid communication with a dialysate-side of said at least one second filtering element, said third end having a second dialysate outlet for discharge of dialysate from said_dialysate-side of said at least one second filtering element; and a connector connected to said second end of said first housing and to said third end of said second housing for the passage of blood from the blood-side of said at least one first filtering element, said connector having a fluid inlet for receiving substitution fluid which mixes with the blood from said first stage before the blood flows to said blood-side of said at least one second filtering element of said second stage, said connector conducting the dialysate from said second stage to said first stage.
7. A dual-stage hemodiafiltration cartridge according to claim 6, wherein said first and second housings are part of a single cartridge member with said connector being integrally formed with said first and second housings.
8. A dual-stage hemodiafiltration cartridge according to claim 6, wherein said connector includes a header space in communication with said blood-side of said at least one first filtering element and with said blood-side of said at least one second filtering element, the substitution fluid flowing in said header space to dilute the blood from said first stage.
9. A dual-stage hemodiafiltration cartridge according to claim 6, further including:
an inter-stage header cap releasably mounted to said connector, said cap having an inlet for receiving substitution fluid.
an inter-stage header cap releasably mounted to said connector, said cap having an inlet for receiving substitution fluid.
10. A dual-stage hemodiafiltration cartridge according to claim 9, further including:
a sealing member for sealing said header space from an external environment, said sealing member being disposed between said inter-stage header cap and said connector, thereby sealing said header space.
a sealing member for sealing said header space from an external environment, said sealing member being disposed between said inter-stage header cap and said connector, thereby sealing said header space.
11. A dual-stage hemodiafiltration cartridge according to claim 6, wherein said connector includes an inter-dialysate port defined at least in part by said first dialysate inlet and said second dialysate outlet, said inter-dialysate port permitting the dialysate to flow from said second stage to said first stage.
12. A dual-stage hemodiafiltration cartridge according to claim 11, further including an inter-aperture cap detachably coupled to said inter-dialysate port and configured to permit the dialysate to flow from said second dialysate outlet to said first dialysate inlet.
13. A dual-stage hemodiafiltration cartridge according to claim 8, wherein said connector includes a member for separating said first and second stages, said member partitioning said header space from said first and second stages, said member communicating with said at least one first and second filtering elements such that said blood-sides of said at least one first and second filtering elements are in fluid communication with said header space to permit the blood to flow from said at least one first filtering element through said header space to said at least one second filtering element.
14. A dual-stage hemodiafiltration cartridge comprising:
a first hemodiafiltration stage including a first housing having first and second ends;
at least one first filtering element disposed between said first and second ends of said first housing, said first end having a blood inlet which communicates with a first side of said at least one first filtering element and a first dialysate outlet which is in fluid communication with a second side of said at least one first filtering element, said second end of said housing having a first dialysate inlet which admits dialysate into said second side of said at least one first filtering element;
a second hemodiafiltration stage including a second housing having third and fourth ends;
at least one second filtering element disposed between said third and fourth ends of said second housing, said fourth end having a blood outlet for passage of blood out of a first side of said at least one second filtering element and a second dialysate inlet which is in fluid communication with a second side of said at least one second filtering element, said third end having a second dialysate outlet for discharge of dialysate from said second side of said at least one second filtering element; and a connector connected to said second end of said first housing and to said third end of said second housing for the passage of blood from the first side of said at least one first filtering element to the first side of said at least one second filtering element, said connector being in fluid communication with the second sides of said at least one first and second filtering elements for passage of dialysate fluid from said second stage to said first stage.
a first hemodiafiltration stage including a first housing having first and second ends;
at least one first filtering element disposed between said first and second ends of said first housing, said first end having a blood inlet which communicates with a first side of said at least one first filtering element and a first dialysate outlet which is in fluid communication with a second side of said at least one first filtering element, said second end of said housing having a first dialysate inlet which admits dialysate into said second side of said at least one first filtering element;
a second hemodiafiltration stage including a second housing having third and fourth ends;
at least one second filtering element disposed between said third and fourth ends of said second housing, said fourth end having a blood outlet for passage of blood out of a first side of said at least one second filtering element and a second dialysate inlet which is in fluid communication with a second side of said at least one second filtering element, said third end having a second dialysate outlet for discharge of dialysate from said second side of said at least one second filtering element; and a connector connected to said second end of said first housing and to said third end of said second housing for the passage of blood from the first side of said at least one first filtering element to the first side of said at least one second filtering element, said connector being in fluid communication with the second sides of said at least one first and second filtering elements for passage of dialysate fluid from said second stage to said first stage.
15. A dual-stage hemodiafiltration device cartridge according to claim 14, wherein said connector has a header space in communication with said first side of said at least one first filtering element and with said first side of said at least one second filtering element, said connector having a substitution fluid inlet which allows substitution fluid to flow into said header space.
16. A dual-stage hemodiafiltration cartridge according to claim 14, wherein said connector includes an inter-dialysate port defined at least in part by said first dialysate inlet and said second dialysate outlet, said inter-dialysate port permitting the dialysate to flow from said second stage to said first stage.
17. A dual-stage hemodiafiltration cartridge according to claim 16, further including an inter-aperture cap detachably coupled to said inter-dialysate port and configured to permit the dialysate to flow from said second dialysate outlet to said first dialysate inlet.
18. A dual-stage hemodiafiltration cartridge comprising:
a first hemodiafiltration stage including a first housing having first and second ends;
at least one first filtering element disposed between said first and second ends of said first housing, said first end having a blood inlet which communicates with a first surface of said at least one first filtering element and a first dialysate outlet which is in fluid communication with a second surface of said at least one first filtering element, said second end of said housing having a first dialysate inlet which admits dialysate to said second surface of said at least one first filtering element;
a second hemodiafiltration stage including a second housing having third and fourth ends;
at least one second filtering element disposed between said third and fourth ends of said second housing, said fourth end having a blood outlet for passage of blood from a first surface of said at least one second filtering element and a second dialysate inlet which admits dialysate to a second surface of said at least one second filtering element, said third end having a second dialysate outlet for discharge of dialysate from said second surface of said at least one second filtering element; and a connector connected to the second end of said first housing and to said third end of said second housing, said connector including a first section for the passage of blood from the first surface of said at least one first filtering element to the first surface of said at least one second filtering element and a second section for passage of dialysate fluid from said second stage to said first stage.
a first hemodiafiltration stage including a first housing having first and second ends;
at least one first filtering element disposed between said first and second ends of said first housing, said first end having a blood inlet which communicates with a first surface of said at least one first filtering element and a first dialysate outlet which is in fluid communication with a second surface of said at least one first filtering element, said second end of said housing having a first dialysate inlet which admits dialysate to said second surface of said at least one first filtering element;
a second hemodiafiltration stage including a second housing having third and fourth ends;
at least one second filtering element disposed between said third and fourth ends of said second housing, said fourth end having a blood outlet for passage of blood from a first surface of said at least one second filtering element and a second dialysate inlet which admits dialysate to a second surface of said at least one second filtering element, said third end having a second dialysate outlet for discharge of dialysate from said second surface of said at least one second filtering element; and a connector connected to the second end of said first housing and to said third end of said second housing, said connector including a first section for the passage of blood from the first surface of said at least one first filtering element to the first surface of said at least one second filtering element and a second section for passage of dialysate fluid from said second stage to said first stage.
19. A dual-stage hemodiafiltration cartridge according to claim 18, wherein said first section includes a header space in communication with said at least one first and second filtering elements, said connector having a substitution-fluid inlet which allows flow of substitution fluid into said header space resulting in the blood in said header space being diluted, said second section includes an inter-dialysate port defined by said first dialysate inlet arid said second dialysate outlet with an inter-aperture cap detachably coupled to said inter-dialysate port and configured so that the dialysate flows directly from said second dialysate outlet to said first dialysate inlet.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/474,855(CON) | 1999-12-30 | ||
US09/474,855 | 1999-12-30 | ||
US09/474,855 US6315895B1 (en) | 1999-12-30 | 1999-12-30 | Dual-stage hemodiafiltration cartridge |
PCT/US2000/035717 WO2001049399A1 (en) | 1999-12-30 | 2000-12-29 | Dual stage hemodiafiltration cartridge |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2395701A1 CA2395701A1 (en) | 2001-07-12 |
CA2395701C true CA2395701C (en) | 2008-11-04 |
Family
ID=23885211
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002395701A Expired - Fee Related CA2395701C (en) | 1999-12-30 | 2000-12-29 | Dual stage hemodiafiltration cartridge |
Country Status (8)
Country | Link |
---|---|
US (1) | US6315895B1 (en) |
EP (1) | EP1253971B1 (en) |
JP (1) | JP4213384B2 (en) |
AU (1) | AU2612201A (en) |
CA (1) | CA2395701C (en) |
DE (1) | DE60033058T2 (en) |
HK (1) | HK1051011A1 (en) |
WO (1) | WO2001049399A1 (en) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2639642C (en) | 1996-12-20 | 2013-01-15 | Siemens Water Technologies Corp. | Scouring method |
US6635179B1 (en) * | 1999-12-30 | 2003-10-21 | Nephros, Inc. | Sterile fluid filtration cartridge and method for using same |
AUPR064800A0 (en) * | 2000-10-09 | 2000-11-02 | Usf Filtration And Separations Group Inc. | Improved membrane filtration system |
AU2002227111A1 (en) * | 2000-10-30 | 2002-05-15 | Nephros, Inc. | Dual-stage filtration cartridge |
WO2002047785A1 (en) * | 2000-12-11 | 2002-06-20 | Nephros, Inc. | Hemodiafiltration / hemofiltration cartridges |
AUPR421501A0 (en) | 2001-04-04 | 2001-05-03 | U.S. Filter Wastewater Group, Inc. | Potting method |
US20030010718A1 (en) | 2001-07-12 | 2003-01-16 | Nxstage Medical, Inc. | Hemodilution cap and methods of use in blood-processing procedures |
AUPR692401A0 (en) | 2001-08-09 | 2001-08-30 | U.S. Filter Wastewater Group, Inc. | Method of cleaning membrane modules |
US7790084B1 (en) * | 2002-05-13 | 2010-09-07 | The United States Of America As Represented By The Secretary Of The Air Force | Method of manufacture of separation devices |
AUPS300602A0 (en) | 2002-06-18 | 2002-07-11 | U.S. Filter Wastewater Group, Inc. | Methods of minimising the effect of integrity loss in hollow fibre membrane modules |
WO2004009158A2 (en) | 2002-07-19 | 2004-01-29 | Baxter International Inc. | Systems and methods for performing peritoneal dialysis |
JP4282598B2 (en) | 2002-10-10 | 2009-06-24 | シーメンス・ウォーター・テクノロジーズ・コーポレーション | Filtration device and method for cleaning the filtration device |
AU2002953111A0 (en) | 2002-12-05 | 2002-12-19 | U. S. Filter Wastewater Group, Inc. | Mixing chamber |
US20040128903A1 (en) * | 2003-01-08 | 2004-07-08 | Kenneth Wexler | Mosquito barrier for drainage structure |
EP1444998A1 (en) * | 2003-02-05 | 2004-08-11 | B. Braun Medizintechnologie GmbH | Bio-liquid treatment device |
EP1466657B1 (en) | 2003-04-11 | 2012-10-03 | Gambro Lundia AB | Filter device having more than one filtration compartment |
AU2003903507A0 (en) | 2003-07-08 | 2003-07-24 | U. S. Filter Wastewater Group, Inc. | Membrane post-treatment |
JP4611982B2 (en) | 2003-08-29 | 2011-01-12 | シーメンス・ウォーター・テクノロジーズ・コーポレーション | Backwash method |
KR20070003783A (en) | 2003-11-14 | 2007-01-05 | 유.에스. 필터 웨이스트워터 그룹, 인크. | Improved module cleaning method |
US8758621B2 (en) | 2004-03-26 | 2014-06-24 | Evoqua Water Technologies Llc | Process and apparatus for purifying impure water using microfiltration or ultrafiltration in combination with reverse osmosis |
JP2007535398A (en) | 2004-04-22 | 2007-12-06 | シーメンス ウォーター テクノロジース コーポレイション | Filtration device including membrane bioreactor and treatment tank for digesting organic substances, and waste liquid treatment method |
CA2571498A1 (en) | 2004-07-02 | 2006-01-12 | U.S. Filter Wastewater Group, Inc. | Gas transfer membrane |
JP2008505197A (en) | 2004-07-05 | 2008-02-21 | シーメンス・ウォーター・テクノロジーズ・コーポレーション | Hydrophilic membrane |
WO2006017911A1 (en) | 2004-08-20 | 2006-02-23 | Siemens Water Technologies Corp. | Square mbr manifolding system |
US8790515B2 (en) | 2004-09-07 | 2014-07-29 | Evoqua Water Technologies Llc | Reduction of backwash liquid waste |
NZ553742A (en) | 2004-09-14 | 2010-09-30 | Siemens Water Tech Corp | Methods and apparatus for removing solids from a membrane module |
CA2579894A1 (en) | 2004-09-15 | 2006-03-23 | Siemens Water Technologies Corp. | Continuously variable aeration |
WO2006049822A1 (en) * | 2004-10-28 | 2006-05-11 | Nxstage Medical, Inc | Blood treatment dialyzer/filter design to trap entrained air in a fluid circuit |
ES2365928T3 (en) | 2004-12-03 | 2011-10-13 | Siemens Industry, Inc. | POST-MEMBRANE TREATMENT. |
EP2394731A1 (en) | 2004-12-24 | 2011-12-14 | Siemens Industry, Inc. | Cleaning in membrane filtration systems |
WO2006066350A1 (en) | 2004-12-24 | 2006-06-29 | Siemens Water Technologies Corp. | Simple gas scouring method and apparatus |
JP4646666B2 (en) * | 2005-03-28 | 2011-03-09 | 旭化成クラレメディカル株式会社 | Medical device fittings |
CA2605757A1 (en) | 2005-04-29 | 2006-11-09 | Siemens Water Technologies Corp. | Chemical clean for membrane filter |
CA2614498A1 (en) | 2005-07-14 | 2007-01-18 | Siemens Water Technologies Corp. | Monopersulfate treatment of membranes |
CN101287538B (en) | 2005-08-22 | 2013-03-06 | 西门子工业公司 | An assembly for water filtration using a tube manifold to minimise backwash |
US20070138090A1 (en) | 2005-10-05 | 2007-06-21 | Jordan Edward J | Method and apparatus for treating wastewater |
WO2008051546A2 (en) | 2006-10-24 | 2008-05-02 | Siemens Water Technologies Corp. | Infiltration/inflow control for membrane bioreactor |
EP2129629A1 (en) | 2007-04-02 | 2009-12-09 | Siemens Water Technologies Corp. | Improved infiltration/inflow control for membrane bioreactor |
US9764288B2 (en) | 2007-04-04 | 2017-09-19 | Evoqua Water Technologies Llc | Membrane module protection |
KR101239780B1 (en) | 2007-05-29 | 2013-03-06 | 지멘스 인더스트리 인코포레이티드 | Membrane cleaning with pulsed airlift pump |
US8114276B2 (en) | 2007-10-24 | 2012-02-14 | Baxter International Inc. | Personal hemodialysis system |
US8057679B2 (en) | 2008-07-09 | 2011-11-15 | Baxter International Inc. | Dialysis system having trending and alert generation |
JP5216916B2 (en) * | 2008-07-15 | 2013-06-19 | ミリメディカル・リミテッド・ライアビリティ・カンパニー | Double fiber bundle dialyzer |
WO2010009518A1 (en) | 2008-07-24 | 2010-01-28 | Siemens Water Technologies Corp. | Frame system for membrane filtration modules |
KR20110044312A (en) | 2008-08-20 | 2011-04-28 | 지멘스 워터 테크놀로지스 코포레이션 | Improved membrane system backwash energy efficiency |
AU2010257526A1 (en) | 2009-06-11 | 2012-01-12 | Siemens Industry, Inc | Methods for cleaning a porous polymeric membrane and a kit for cleaning a porous polymeric membrane |
US8535536B1 (en) | 2009-07-04 | 2013-09-17 | University Of Utah Research Foundation | Cross-flow split-thin-flow cell |
WO2011136888A1 (en) | 2010-04-30 | 2011-11-03 | Siemens Industry, Inc | Fluid flow distribution device |
EP2618916A4 (en) | 2010-09-24 | 2016-08-17 | Evoqua Water Technologies Llc | Fluid control manifold for membrane filtration system |
KR20140097140A (en) | 2011-09-30 | 2014-08-06 | 에보쿠아 워터 테크놀로지스 엘엘씨 | Isolation valve |
US9604166B2 (en) | 2011-09-30 | 2017-03-28 | Evoqua Water Technologies Llc | Manifold arrangement |
DK3603693T3 (en) | 2011-12-29 | 2022-05-16 | Delcath Systems Inc | FILTER AND FRAME APPLIANCE AND METHOD OF USE |
EP2866922B1 (en) | 2012-06-28 | 2018-03-07 | Evoqua Water Technologies LLC | A potting method |
AU2013315547A1 (en) | 2012-09-14 | 2015-02-26 | Evoqua Water Technologies Llc | A polymer blend for membranes |
US9962865B2 (en) | 2012-09-26 | 2018-05-08 | Evoqua Water Technologies Llc | Membrane potting methods |
GB2520871B (en) | 2012-09-26 | 2020-08-19 | Evoqua Water Tech Llc | Membrane securement device |
AU2013323934A1 (en) | 2012-09-27 | 2015-02-26 | Evoqua Water Technologies Llc | Gas scouring apparatus for immersed membranes |
HUE061765T2 (en) | 2013-10-02 | 2023-08-28 | Rohm & Haas Electronic Mat Singapore Pte Ltd | Device for repairing a membrane filtration module |
WO2016130128A1 (en) * | 2015-02-12 | 2016-08-18 | Mirimedical Llc | Improved double fiber bundle dialyzer |
CN116206744A (en) | 2015-06-25 | 2023-06-02 | 甘布罗伦迪亚股份公司 | Medical device systems and methods with distributed databases |
US10322375B2 (en) | 2015-07-14 | 2019-06-18 | Evoqua Water Technologies Llc | Aeration device for filtration system |
DE102016117599A1 (en) | 2016-09-19 | 2018-03-22 | B. Braun Avitum Ag | Sterile containers with a sterile barrier separate from a primary packaging, as well as methods for producing a sterile package |
AU2017381172A1 (en) | 2016-12-21 | 2019-06-13 | Gambro Lundia Ab | Medical device system including information technology infrastructure having secure cluster domain supporting external domain |
US10821216B1 (en) | 2017-07-03 | 2020-11-03 | Nephros Inc. | Method and apparatus for a hemodiafiltration module for use with a dialysis machine |
DE102018008459A1 (en) * | 2018-10-29 | 2020-04-30 | Enmodes Gmbh | Device for the exchange of substances between blood and at least one gas / gas mixture |
US10926019B2 (en) | 2019-06-05 | 2021-02-23 | Choon Kee Lee | Gradient dialysate hemodiafiltration |
US20220088527A1 (en) * | 2020-09-18 | 2022-03-24 | Pall Corporation | Branched filter and method of use |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3946731A (en) | 1971-01-20 | 1976-03-30 | Lichtenstein Eric Stefan | Apparatus for extracorporeal treatment of blood |
FR2231421B1 (en) | 1973-05-30 | 1976-05-07 | Rhone Poulenc Ind | |
US4118314A (en) | 1974-01-09 | 1978-10-03 | Seisan Kaihatsu Kagaku Kenkyusho | Apparatus for treatment of artificial kidney dialyzing fluid |
US3976576A (en) | 1974-04-01 | 1976-08-24 | The University Of Utah | Dialyzer cartridge |
US3878095A (en) | 1974-05-02 | 1975-04-15 | Advanced Medical Sciences Inc | Dialysis apparatus |
US4134834A (en) | 1976-01-06 | 1979-01-16 | Artificial And Transplant Organs, Inc. | Hemodialysis apparatus |
DE2803344C3 (en) | 1978-01-26 | 1981-09-24 | Sartorius GmbH, 3400 Göttingen | Device for mass transfer between fluids with the interposition of a membrane |
JPS5649160A (en) | 1979-04-09 | 1981-05-02 | Brumfield Robert Clarence | Substance transporter and its manufacture |
US4381999A (en) | 1981-04-28 | 1983-05-03 | Cobe Laboratories, Inc. | Automatic ultrafiltration control system |
SE427619B (en) | 1981-10-05 | 1983-04-25 | Gambro Lundia Ab | A filtering |
SE425216B (en) | 1981-10-05 | 1982-09-13 | Gambro Ab | A filtering |
US4647378A (en) | 1983-03-23 | 1987-03-03 | Nihon Medical Engineering Co., Ltd. | Blood dialyzing method and apparatus |
FI885009A (en) * | 1987-11-02 | 1989-05-03 | Tokyo Bi Tech Lab Inc | FIBERMEMBRAN SAMT FOERFARANDE OCH ANORDNING FOER RENGOERING AV BLOD. |
US5069788A (en) | 1989-08-24 | 1991-12-03 | Pfizer Hospital Products Groups, Inc. | Multi-pass blood washing and plasma removal device and method |
US5194157A (en) * | 1990-03-09 | 1993-03-16 | Sorin Biomedica Emodialisi Srl | Blood purifying equipment particularly for the treatment of patients suffering from renal insufficiency, and a method of producing a reinfusion liquid for haemodiafiltration (HDF) |
FR2660866B1 (en) | 1990-04-13 | 1992-06-12 | Hogamed | PROCESS AND DEVICE FOR PREPARING A SUBSTITUTION LIQUID. |
DK172894B1 (en) | 1991-01-03 | 1999-09-27 | Niels Aage Aunsholt | hemodialysis |
US5486286A (en) | 1991-04-19 | 1996-01-23 | Althin Medical, Inc. | Apparatus for performing a self-test of kidney dialysis membrane |
IT1245999B (en) | 1991-05-29 | 1994-11-07 | Bellco Spa | EQUIPMENT FOR HEMODIAFILTRATION TREATMENTS. |
US5244568A (en) | 1991-11-15 | 1993-09-14 | Baxter International Inc. | Automated hemodialysis chemical treatment system with control valve and proportioning pumps |
FR2691364B1 (en) | 1992-05-19 | 1999-08-20 | Hospal Ind | ARTIFICIAL KIDNEY WITH DIALYSIS LIQUID FILTERING DEVICE. |
ES2139783T5 (en) | 1994-07-13 | 2005-10-16 | Fresenius Medical Care Deutschland Gmbh | PREPARATION OF SUBSTITUTE LIQUID IN A HEMOFILTRATED OR FILTERED HEMO-DAY APPLIANCE. |
DE19523505A1 (en) * | 1994-07-13 | 1996-01-18 | Fresenius Ag | Haemodiafiltration appliance with blood filter divided by membrane into two chambers |
US5591344A (en) | 1995-02-13 | 1997-01-07 | Aksys, Ltd. | Hot water disinfection of dialysis machines, including the extracorporeal circuit thereof |
DE19534417A1 (en) | 1995-09-16 | 1997-03-20 | Fresenius Ag | Method for checking at least one filter arranged in the dialysis fluid system of a device for extracorporeal blood treatment |
SE510127C2 (en) | 1996-06-13 | 1999-04-19 | Althin Medical Ab | Disposable Hemodia Filtration Kit |
US5902336A (en) | 1996-10-15 | 1999-05-11 | Mirimedical, Inc. | Implantable device and method for removing fluids from the blood of a patient method for implanting such a device and method for treating a patient experiencing renal failure |
WO1998050090A1 (en) | 1997-05-08 | 1998-11-12 | Scitec K.K. | Bacteria removing filter unit for hemodialyzer and hemodialyzer with bacteria removing filter |
IT1293309B1 (en) | 1997-07-09 | 1999-02-16 | Sis Ter Spa | BLOOD TREATMENT EQUIPMENT WITH MEMBRANE EXCHANGE DEVICE |
IT1299946B1 (en) | 1998-04-01 | 2000-04-04 | Bellco Spa | HEMODIALYSIS MACHINE. |
US6303036B1 (en) | 1998-07-31 | 2001-10-16 | Nephros, Inc. | Method and apparatus for efficient hemodiafiltration |
ATE346677T1 (en) | 1998-10-30 | 2006-12-15 | Nephros Inc | SYSTEM FOR NON-ISOSMOTIC DIAFILTRATION |
SE515122C2 (en) | 1999-01-29 | 2001-06-11 | Gambro Lundia Ab | Filters and method of manufacturing filters for dialysis |
-
1999
- 1999-12-30 US US09/474,855 patent/US6315895B1/en not_active Expired - Lifetime
-
2000
- 2000-12-29 JP JP2001549759A patent/JP4213384B2/en not_active Expired - Fee Related
- 2000-12-29 WO PCT/US2000/035717 patent/WO2001049399A1/en active IP Right Grant
- 2000-12-29 EP EP00989637A patent/EP1253971B1/en not_active Expired - Lifetime
- 2000-12-29 AU AU26122/01A patent/AU2612201A/en not_active Abandoned
- 2000-12-29 DE DE60033058T patent/DE60033058T2/en not_active Expired - Lifetime
- 2000-12-29 CA CA002395701A patent/CA2395701C/en not_active Expired - Fee Related
-
2003
- 2003-05-06 HK HK03103243A patent/HK1051011A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2395701A1 (en) | 2001-07-12 |
JP2003518996A (en) | 2003-06-17 |
DE60033058T2 (en) | 2007-06-21 |
JP4213384B2 (en) | 2009-01-21 |
US6315895B1 (en) | 2001-11-13 |
WO2001049399A1 (en) | 2001-07-12 |
AU2612201A (en) | 2001-07-16 |
HK1051011A1 (en) | 2003-07-18 |
EP1253971A1 (en) | 2002-11-06 |
EP1253971A4 (en) | 2003-09-10 |
DE60033058D1 (en) | 2007-03-08 |
EP1253971B1 (en) | 2007-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2395701C (en) | Dual stage hemodiafiltration cartridge | |
EP1351751B1 (en) | Hemodiafiltration / hemofiltration cartridges | |
US4861485A (en) | Hemodiafiltration device | |
KR100649260B1 (en) | Dual-stage filtration cartridge | |
EP1251943B1 (en) | Sterile fluid filtration cartridge and method for using same | |
US7622041B2 (en) | Method for making a filter device having more than one filtration compartment | |
US5942112A (en) | Hollow fiber ultradialyzer apparatus | |
CN100518836C (en) | Diafiltration method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20141229 |